These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Primary cerebral non-Hodgkin's lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the registry of non-Hodgkin's lymphoma in western Denmark, LYFO and the cancer registry, Kraeftens Bekaempelse]. Jensen MK, d'Amore FA, Jensen MK, Christensen BE, Thorling K, Pedersen M, Johansen P, Boesen AM, Andersen E. Ugeskr Laeger; 1996 Jul 29; 158(31):4406-12. PubMed ID: 8759999 [Abstract] [Full Text] [Related]
5. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma. Bierman P, Giglio P. Hematol Oncol Clin North Am; 2005 Aug 29; 19(4):597-609, v. PubMed ID: 16083825 [Abstract] [Full Text] [Related]
6. [Primary non-Hodgkin lymphomas of the central nervous system]. Hutschenreuter M, Wildemann B, Schackert G, Herrmann R, Hacke W. Nervenarzt; 1991 Feb 29; 62(2):69-79. PubMed ID: 2034311 [Abstract] [Full Text] [Related]
7. [Primary non-Hodgkin's malignant lymphoma of the central nervous system]. Monjour A, Poisson M, Kujas M, Delattre JY. Rev Neurol (Paris); 1992 Feb 29; 148(10):589-600. PubMed ID: 1295053 [Abstract] [Full Text] [Related]
8. [Primary central nervous system lymphomas]. Hrudková M, Belada D, Smolej L, Zák P, Malý J. Vnitr Lek; 2010 Aug 29; 56(8):795-800. PubMed ID: 20845611 [Abstract] [Full Text] [Related]
9. Primary malignant non-Hodgkin's lymphoma of the central nervous system. Bonnín JM, Garcia JH. Pathol Annu; 1987 Aug 29; 22 Pt 1():353-75. PubMed ID: 3554121 [No Abstract] [Full Text] [Related]
10. Management of immunocompetent patients with primary central nervous system lymphoma. Chimienti E, Spina M, Vaccher E, Tirelli U. Clin Lymphoma Myeloma; 2009 Oct 29; 9(5):353-64. PubMed ID: 19858054 [Abstract] [Full Text] [Related]
12. [Primary non-Hodgkin's lymphomas of the central nervous system. Still more questions than answers in the treatment?]. Hansen PB, Jensen MK. Ugeskr Laeger; 2007 Jun 04; 169(23):2187-9. PubMed ID: 17592682 [Abstract] [Full Text] [Related]
13. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry. Krogh-Jensen M, D'Amore F, Jensen MK, Christensen BE, Thorling K, Pedersen M, Johansen P, Boesen AM, Andersen E. Leuk Lymphoma; 1995 Oct 04; 19(3-4):223-33. PubMed ID: 8535213 [Abstract] [Full Text] [Related]
14. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma. Karantanis D, O'Neill BP, Subramaniam RM, Peller PJ, Witte RJ, Mullan BP, Wiseman GA. Clin Nucl Med; 2007 Apr 04; 32(4):271-4. PubMed ID: 17413571 [Abstract] [Full Text] [Related]
19. A virtual tissue bank for primary central nervous system lymphomas in immunocompetent individuals. Ponzoni M, Kwee I, Mazzucchelli L, Ferreri AJ, Zucca E, Doglioni C, Cavalli F, Bertoni F. Pathobiology; 2007 Apr 04; 74(4):264-9. PubMed ID: 17709970 [Abstract] [Full Text] [Related]